60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.89 -0.03 (-3.48%)
As of: Oct 21, 2026 · 3:58 PM EDT

60 Degrees Pharmaceuticals (SXTP) Debt Ratio (2022 - 2025)

Updated

60 Degrees Pharmaceuticals' (SXTP) Debt Ratio stood at 0.03 in Q4 2025, up 5.2% from 0.03 a year earlier.

Analysis

60 Degrees Pharmaceuticals (SXTP) Debt Ratio (2022 - 2025) Analysis & Trends

Starting with Q4 2022, 60 Degrees Pharmaceuticals' Debt Ratio history includes 6 quarters.

  • Across earlier years, Debt Ratio came in at 0.03 in FY2024, 0.00 in FY2023 (-100.0%) and 17.15 in FY2022.
  • The Q4 2025 figure is the highest quarterly Debt Ratio since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 60 Degrees Pharmaceuticals 2.37 Mn 1.35 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.03
Dec 31, 2024 0.03
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.24
Jun 30, 2023 7.05
Dec 31, 2022 17.15
API Access

60 Degrees Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SXTP&period=max&api_key=YOUR_API_KEY